Implications of the NADase CD38 in COVID pathophysiology.
Physiol Rev
; 102(1): 339-341, 2022 01 01.
Article
in En
| MEDLINE
| ID: mdl-34494892
Full text:
1
Database:
MEDLINE
Main subject:
Membrane Glycoproteins
/
ADP-ribosyl Cyclase 1
/
SARS-CoV-2
/
COVID-19
Type of study:
Clinical_trials
/
Guideline
Limits:
Humans
Language:
En
Journal:
Physiol Rev
Year:
2022
Type:
Article